FDA Grants Orphan Drug Designation to Gene Therapy Treatment for Angelman Syndrome
FDA Grants Orphan Drug Designation to Gene Therapy Treatment for Angelman Syndrome

Agilis Biotherapeutics and Dr. Edwin Weeber take giant step forward toward a functional cure for Angelman Syndrome.  For Further information, read the press release here.

X
X